BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18178795)

  • 1. Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection.
    Kanda T; Wakino S; Hayashi K; Plutzky J
    J Am Soc Nephrol; 2008 Jan; 19(1):4-7. PubMed ID: 18178795
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.
    Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S162-94. PubMed ID: 20591029
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of renal microvascular complications in diabetes mellitus.
    Veldman BA; Vervoort G
    Neth J Med; 2002 Nov; 60(10):390-6. PubMed ID: 12607589
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes: response to Shultis et al.
    Varon FN
    Diabetes Care; 2007 Dec; 30(12):e138; author reply e139. PubMed ID: 18042747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetes mellitus as cause of terminal renal failure. An epidemic of the 21st Century?].
    Carretero-Dios D; Pérez-García R; Rodríguez-Benítez P; Villaverde M; Gómez-Campderá F; Valderrábano F
    Nefrologia; 2001; 21 Suppl 3():83-7. PubMed ID: 11642212
    [No Abstract]   [Full Text] [Related]  

  • 6. The diabetic patient with renal failure.
    Ritz E; Schömig M
    Nefrologia; 2000; 20 Suppl 3():16-24. PubMed ID: 10835873
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiologic analysis of the increase in terminal renal insufficiency associated with type 2 diabetes mellitus].
    Lorenzo V; Martín Urcuyo B
    Nefrologia; 2000; 20 Suppl 5():77-81. PubMed ID: 11190112
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microangiopathies of diabetics (epidemiologic and clinical observations].
    Tornóczky J; Vastag O; Sziládi E; Kottmayer K; Muth L; Rucker R
    Orv Hetil; 1987 Jan; 128(3):137-40, 143-4. PubMed ID: 3562010
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
    Seufert J
    Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications.
    Evans N; Forsyth E
    Phys Ther; 2004 May; 84(5):454-63. PubMed ID: 15113278
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    Acta Diabetol; 2010 Mar; 47(1):1-4. PubMed ID: 20099002
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan.
    Chou CK; Weng SW; Chang HW; Chen CY; Su SC; Liu RT
    Diabetes Res Clin Pract; 2008 Sep; 81(3):331-7. PubMed ID: 18639951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage renal disease in NIDDM: a consequence of microangiopathy alone?
    Raine AE; Bilous RW
    Diabetologia; 1996 Dec; 39(12):1673-5. PubMed ID: 9081854
    [No Abstract]   [Full Text] [Related]  

  • 16. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
    Azadbakht L; Atabak S; Esmaillzadeh A
    Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
    Abuissa H; O'Keefe J
    Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking, smoking cessation, and diabetes.
    Tonstad S
    Diabetes Res Clin Pract; 2009 Jul; 85(1):4-13. PubMed ID: 19427049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of diabetes in cardiovascular patients: diabetic heart disease.
    Peter R; Cox A; Evans M
    Heart; 2008 Mar; 94(3):369-75. PubMed ID: 18276822
    [No Abstract]   [Full Text] [Related]  

  • 20. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.